Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Acuvue Oasys

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1 (1)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05331859Phase 1UnknownPrimary

Topical Insulin Versus Autologous Serum After Corneal Surgeries

NCT03163641Not ApplicableCompletedPrimary

Safety and Effectiveness of OBG vs.a Bandage Contact Lens for Large Corneal Epithelial Defects in Patients Post-PRK.

NCT01441648Completed

Influence of Cosmetic Color Tinted Contact Lenses on the Ocular Surface

Showing all 3 trials

Research Network

Common Treatments

  • Acuvue Oasys1
  • Insulin1
  • Autologous Serum As1
  • Contact Lens Wear1
  • Conventional1

Active Sponsors

  • Eyegate Pharmaceuticals, Inc.1
  • National Taiwan University Hospital1
  • Benha University1
  • Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation1

Top Investigators

Related Conditions

  • Hypertrophy Conjunctiva1
  • Conjunctival Infections Irritations And Inflammations1
  • Corneal Pannus1

Activity Timeline